PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA

Author(s)

• 

  Shahyan U. Rehman, MD (he/him/his)

  General Surgery Resident
  Yale School of Medicine / Yale New Haven Hospital
  New Haven, Connecticut, United States

  Slides

Co-Author(s)

• AK

  Angela Kim, PhD Student

  Yale School of Medicine
  New Haven, Connecticut, United States
• RS

  Ranjini K. Sundaram, PhD

  Yale School of Medicine
  New Haven, Connecticut, United States
• PR

  Paula Rivera Carrasquillo, MD Student

  University of Puerto Rico
  New Haven, Connecticut, United States
• SG

  Sophia Gayle, PhD

  Cybrexa Therapeutics
  New Haven, Connecticut, United States
• VP

  Vishwas Paralkar, PhD

  Cybrexa Therapeutics
  New Haven, Connecticut, United States
• EC

  Emily Christison-Lagay, MD

  Associate Professor of Surgery
  Yale School of Medicine
  New Haven, Connecticut, United States
• 

  Juan C. Vasquez, MD

  Assistant Professor of Pediatrics
  Yale School of Medicine
  New Haven, Connecticut, United States